In Re Copley Pharmaceutical, Inc.

1 F. Supp. 2d 1407, 1998 U.S. Dist. LEXIS 6344, 1998 WL 217942
CourtDistrict Court, D. Wyoming
DecidedApril 30, 1998
DocketMDL 1013
StatusPublished
Cited by20 cases

This text of 1 F. Supp. 2d 1407 (In Re Copley Pharmaceutical, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Wyoming primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In Re Copley Pharmaceutical, Inc., 1 F. Supp. 2d 1407, 1998 U.S. Dist. LEXIS 6344, 1998 WL 217942 (D. Wyo. 1998).

Opinion

ORDER ON JOINT PETITION OF CLASS COUNSEL AND PLAINTIFFS’ STEERING COMMITTEE FOR AN AWARD OF ATTORNEYS’ FEES AND REIMBURSEMENT OF LITIGATION EXPENSES

BRIMMER, District Judge.

This matter came before the Court upon the Joint'Petition of Class Counsel and Plaintiffs’ Steering Committee seeking an award of attorneys’ fees and expenses from the common fund created by the settlement of this action. - The Court, having heard oral argument, having reviewed the materials on file, and being fully advised in the premises herein, hereby FINDS and ORDERS as follows:

Background

The Court has provided a more detailed history of this action in its prior orders. See In re Copley Pharmaceutical, Inc., 161 F.R.D. 456 (D.Wyo.1995); In re Copley Pharmaceutical, Inc., 158 F.R.D. 485 (D.Wyo.1994); Order Approving Settlement, November 15, 1995. Suffice it to say that this action arose out of the contamination with pseudomonas fluorescens of four batches of Albuterol manufactured by Defendant Copley Pharmaceutical, Inc. Individuals believing that this organism, or other contaminants in Defendant’s products, caused injuries to themselves or others brought suit in state and federal courts throughout the country. Defendant removed those actions that it could to federal court, and eventually sought relief from the Judicial Panel for Multi-Dis-trict Litigation. On June 7, 1994, the MDL Panel consolidated all federal cases against Defendant before this Court.

Following certification as a class action and appointment of class counsel, this action moved forward with surprising speed and efficiency. During expedited discovery, class counsel reviewed and analyzed more than 125,000 pages of documents and deposed roughly one hundred witnesses. One year and seven days after consolidation before this Court, trial commenced. And after 42 days of trial, in which each side presented an impressive case, the parties entered into a preliminary settlement agreement.

Class counsel and Plaintiffs’ Steering Committee (“class counsel”) now seek attorneys’ fees and expenses pursuant to that settlement agreement (“Agreement”). Class counsel requests an award of 25% of what they deem to be a $150 million fund, resulting in a fee of $37.5 million; Defendant urges the Court to award roughly 20% of the $60 million that it estimates has already been paid out under the fund, resulting in a fee of $12 million.

The Settlement Agreement

The Agreement, perhaps surprisingly, does not fix the amount of class counsel’s attorneys’ fees, instead leaving this matter to the Court’s discretion. Thus the Agreement merely provides that “Class Counsel shall receive an award in an amount approved by the Court, based upon the Gross Amount of money and benefits received by the Class and Claimants from all settlement funds....” (Agreement ¶ 8.1.) “ ‘Gross Amount’ as used in paragraph 8.1” is defined by the Agreement as “Copley’s maximum potential contribution to the settlement funds before any remittitur, i.e., $150,000,000.” (Agreement ¶ 3.19.) Private fee arrangements between claimants and non-class counsel are also addressed by the Agreement, which provides that “the Court shall reserve the power to set maximum limits on contingent fees, and [ ] the Court may make appropriate reductions on such contingent fee amounts for the cost of ‘common benefit’ services provided by Class Counsel.” (Agreement ¶ 8.3.)

*1409 While largely silent on the amount of the fees, the Agreement does explicitly address the allocation of fees. For Funds One, Two, and Three, the Agreement provides that each claimant meeting the fund’s criteria will receive an award “less his or her pro rata share of attorneys’ fees, costs, and administrative expenses.” (Agreement ¶¶ 5.3.1, 5.4.1, 5.5.1.) Further, the Agreement provides that the money in Fund Four will be used for payments to claimants and for “payment of attorneys fees, litigation costs and administrative costs.... ” (Agreement ¶ 5.6.5.)

The Supplement to the Agreement broadens the definition of “Claimant” to include “Additional Claimants,” or “those who timely requested exclusion from the class.” (Supp. Agreement ¶¶ 3.6, 9.6.) However, the Supplement explicitly provides that “[n]o deductions will be made from any amounts paid to such Claimants for their pro rata share of attorneys’ fees or litigation expenses awarded by the Court pursuant to paragraph 8.1.” (Supp. Agreement ¶ 9.6.3.)

The Agreement also addresses Defendant’s responsibilities regarding fees and expenses. The Agreement provides that “[i]f the total money paid from all settlement funds to Claimants and for attorneys’ fees, litigation costs and administrative expenses pursuant to section 8 of this Agreement is more than $65,000,000,” Defendant’s remitti-tur will be reduced by “an amount equal to each Claimants’ [sic] per capita share of attorneys’ fees, costs, and administrative expenses awarded or paid pursuant to section 8.... ” (Agreement ¶¶ 5.3.3(h), 5.4.3(h), 5.5.3(h).)

Discussion

The settlement in this case created a “common fund” from which the plaintiff class obtained a benefit. In a rare exception to the American rule that parties bear them own costs in litigation, “a litigant or lawyer who recovers a common fund for the benefit of persons other than himself or his client is entitled to a reasonable attorney’s fee from the fund as a whole.” Boeing Co. v. Van Gemert, 444 U.S. 472, 478, 100 S.Ct. 745, 62 L.Ed.2d 676 (1980); see also Aguinaga v. United Food & Commercial Workers Int’l Union, 993 F.2d 1480, 1482 (10th Cir.1993); Brown v. Phillips Petroleum Co., 838 F.2d 451, 454 (10th Cir.1988). This exercise of the federal court’s historic equity jurisdiction, see Sprague v. Ticonic Nat’l Bank, 307 U.S. 161, 164, 59 S.Ct. 777, 83 L.Ed. 1184 (1939), prevents the unjust enrichment (at the successful litigant’s expense) of “persons who obtain the benefit of a lawsuit without contributing to its costs,” see Boeing, 444 U.S. at 478, 100 S.Ct. 745. Accordingly, the attorneys who contributed to the creation of the common fund in this case are entitled to a reasonable fee therefrom.

Before considering the proper methodology for awarding attorneys’ fees out of a common fund, the Court feels compelled to define its role in these proceedings. When an attorney makes a claim for fees from a common fund, his interest is “adverse to the interest of the class in obtaining recovery because the fees come out of the common fund set up for the benefit of the class.” Rawlings v. Prudential-Bache Properties, Inc., 9 F.3d 513, 516 (6th Cir.1993).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ramah Navajo Chapter v. Jewell
167 F. Supp. 3d 1217 (D. New Mexico, 2016)
In Re All Individual Kugel Mesh Cases
Superior Court of Rhode Island, 2009
Ritter, Laber & Associates, Inc. v. Koch Oil, Inc.
2007 ND 163 (North Dakota Supreme Court, 2007)
Brody v. Hellman
167 P.3d 192 (Colorado Court of Appeals, 2007)
Turner v. Murphy Oil USA, Inc.
472 F. Supp. 2d 830 (E.D. Louisiana, 2007)
In Re New Mexico Indirect Purchasers Microsoft Corp.
2007 NMCA 007 (New Mexico Court of Appeals, 2006)
In Re Synthroid Marketing Litigation
201 F. Supp. 2d 861 (N.D. Illinois, 2002)
In Re: Cendant Corp Prides Litigation
243 F.3d 722 (Third Circuit, 2001)
In Re: Cendant Corporation Prides Litigation
243 F.3d 722 (Third Circuit, 2001)
In Re: Copley v.
Tenth Circuit, 2000
Waters v. International Precious Metals Corp.
190 F.3d 1291 (Eleventh Circuit, 1999)
Waters v. International Precious
190 F.3d 1291 (Eleventh Circuit, 1999)
In Re Copley Pharmaceutical, Inc.
50 F. Supp. 2d 1141 (D. Wyoming, 1999)
Ramah Navajo Chapter v. Babbitt
50 F. Supp. 2d 1091 (D. New Mexico, 1999)
In re Nasdaq Market-Makers Antitrust Litigation
187 F.R.D. 465 (S.D. New York, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
1 F. Supp. 2d 1407, 1998 U.S. Dist. LEXIS 6344, 1998 WL 217942, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-copley-pharmaceutical-inc-wyd-1998.